Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jason C Gallagher

Showing results (51-60 of 64) with videos related to

Pageof 7
Sort By:
American Journal of Pharmaceutical Education|September 6, 2018
Preventing the Post-Antibiotic Era by Training Future Pharmacists as Antimicrobial StewardsJason C Gallagher, Julie Ann Justo, Elias B Chahine, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 13, 2023
Antibiotic Myths for the Infectious Diseases ClinicianErin K McCreary, Melissa D Johnson, Travis M Jones, et al.
Pharmacotherapy|February 13, 2013
Desired professional development pathways for clinical pharmacists, Stacy S Shord, Terry L Schwinghammer, et al.
Antimicrobial Agents and Chemotherapy|May 10, 2017
Multicenter Study of Outcomes with Ceftazidime-Avibactam in Patients with Carbapenem-Resistant Enterobacteriaceae InfectionsMadeline King, Emily Heil, Safia Kuriakose, et al.
Open Forum Infectious Diseases|November 12, 2024
Let's Have a Chat: How Well Does an Artificial Intelligence Chatbot Answer Clinical Infectious Diseases Pharmacotherapy Questions?Wesley D Kufel, Kathleen D Hanrahan, Robert W Seabury, et al.
Infection Control and Hospital Epidemiology|February 2, 2022
Poor outcomes in both infection and colonization with carbapenem-resistant EnterobacteralesJessica R Howard-Anderson, Michelle Earley, Lauren Komarow, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 20, 2021
Lessons Learned from Coronavirus Disease 2019 (COVID-19) Therapies: Critical Perspectives From the Infectious Diseases Society of America (IDSA) COVID-19 Treatment Guideline PanelAdarsh Bhimraj, Rebecca L Morgan, Amy Hirsch Shumaker, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 20, 2021
Therapeutic Emergency Use Authorizations (EUAs) During Pandemics: Double-edged SwordsAdarsh Bhimraj, Rebecca L Morgan, Amy Hirsch Shumaker, et al.
The Journal of Antimicrobial Chemotherapy|June 12, 2024
Clinical outcomes in patients infected with ertapenem-only-resistant Enterobacterales versus multi-carbapenem-resistant EnterobacteralesGregory Weston, Abhigya Giri, Lauren Komarow, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 28, 2014
Knowledge and attitudes of doctor of pharmacy students regarding the appropriate use of antimicrobialsJulie Ann Justo, Timothy P Gauthier, Marc H Scheetz, et al.
Pageof 7

Showing results (51-60 of 64) with videos related to

Sort By:
Pageof 7
American Journal of Pharmaceutical Education|September 6, 2018
Preventing the Post-Antibiotic Era by Training Future Pharmacists as Antimicrobial StewardsJason C Gallagher, Julie Ann Justo, Elias B Chahine, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 13, 2023
Antibiotic Myths for the Infectious Diseases ClinicianErin K McCreary, Melissa D Johnson, Travis M Jones, et al.
Pharmacotherapy|February 13, 2013
Desired professional development pathways for clinical pharmacists, Stacy S Shord, Terry L Schwinghammer, et al.
Antimicrobial Agents and Chemotherapy|May 10, 2017
Multicenter Study of Outcomes with Ceftazidime-Avibactam in Patients with Carbapenem-Resistant Enterobacteriaceae InfectionsMadeline King, Emily Heil, Safia Kuriakose, et al.
Open Forum Infectious Diseases|November 12, 2024
Let's Have a Chat: How Well Does an Artificial Intelligence Chatbot Answer Clinical Infectious Diseases Pharmacotherapy Questions?Wesley D Kufel, Kathleen D Hanrahan, Robert W Seabury, et al.
Infection Control and Hospital Epidemiology|February 2, 2022
Poor outcomes in both infection and colonization with carbapenem-resistant EnterobacteralesJessica R Howard-Anderson, Michelle Earley, Lauren Komarow, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 20, 2021
Lessons Learned from Coronavirus Disease 2019 (COVID-19) Therapies: Critical Perspectives From the Infectious Diseases Society of America (IDSA) COVID-19 Treatment Guideline PanelAdarsh Bhimraj, Rebecca L Morgan, Amy Hirsch Shumaker, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 20, 2021
Therapeutic Emergency Use Authorizations (EUAs) During Pandemics: Double-edged SwordsAdarsh Bhimraj, Rebecca L Morgan, Amy Hirsch Shumaker, et al.
The Journal of Antimicrobial Chemotherapy|June 12, 2024
Clinical outcomes in patients infected with ertapenem-only-resistant Enterobacterales versus multi-carbapenem-resistant EnterobacteralesGregory Weston, Abhigya Giri, Lauren Komarow, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 28, 2014
Knowledge and attitudes of doctor of pharmacy students regarding the appropriate use of antimicrobialsJulie Ann Justo, Timothy P Gauthier, Marc H Scheetz, et al.
Pageof 7